Absci Corp (ABSI) concluded trading on Wednesday at a closing price of $2.90, with 3.53 million shares of worth about $10.24 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -28.04% during that period and on March 26, 2025 the price saw a loss of about -5.54%. Currently the company’s common shares owned by public are about 115.36M shares, out of which, 102.95M shares are available for trading.
Stock saw a price change of -2.68% in past 5 days and over the past one month there was a price change of -27.86%. Year-to-date (YTD), ABSI shares are showing a performance of 10.69% which decreased to -41.41% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.45 but also hit the highest price of $6.72 during that period. The average intraday trading volume for Absci Corp shares is 5.65 million. The stock is currently trading -8.98% below its 20-day simple moving average (SMA20), while that difference is down -23.99% for SMA50 and it goes to -22.32% lower than SMA200.
Absci Corp (NASDAQ: ABSI) currently have 115.36M outstanding shares and institutions hold larger chunk of about 56.94% of that.
The stock has a current market capitalization of $369.27M and its 3Y-monthly beta is at 2.15. It has posted earnings per share of -$0.93 in the same period. It has Quick Ratio of 4.67 while making debt-to-equity ratio of 0.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ABSI, volatility over the week remained 5.38% while standing at 7.84% over the month.
Stock’s fiscal year EPS is expected to rise by 10.76% while it is estimated to increase by 22.86% in next year. EPS is likely to grow at an annualized rate of 18.87% for next 5-years, compared to annual growth of -29.30% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Needham on January 22, 2025 offering a Buy rating for the stock and assigned a target price of $9 to it. Coverage by Guggenheim stated Absci Corp (ABSI) stock as a Buy in their note to investors on October 02, 2024, suggesting a price target of $10 for the stock. On July 03, 2024, Morgan Stanley Initiated their recommendations, while on March 14, 2024, Scotiabank Initiated their ratings for the stock with a price target of $13. Stock get an Overweight rating from KeyBanc Capital Markets on December 05, 2023.
